1. A candidate for lung cancer treatment: arsenic trioxide
    W. Huang et al, 2019, Clinical and Translational Oncology CrossRef
  2. Arsenic trioxide targets MTHFD1 and SUMO-dependent nuclear de novo thymidylate biosynthesis
    Elena Kamynina et al, 2017, Proceedings of the National Academy of Sciences CrossRef
  3. Therapeutic Potential of Delivering Arsenic Trioxide into HPV-Infected Cervical Cancer Cells Using Liposomal Nanotechnology
    Xiaoyan Wang et al, 2016, Nanoscale Research Letters CrossRef
  4. E2F1 downregulation by arsenic trioxide in lung adenocarcinoma
    SZE-KWAN LAM et al, 2014, International Journal of Oncology CrossRef
  5. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma
    Sze-Kwan Lam et al, 2016, Lung Cancer CrossRef
  6. Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma
    Yuzo Sato et al, 2021, Frontiers in Pharmacology CrossRef
  7. Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats
    Gabriela Velasco-Loyden et al, 2017, Tumor Biology CrossRef
  8. Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
    Cyrus R. Kumana et al, 2022, Frontiers in Oncology CrossRef
  9. Tumour growth-suppressive effect of arsenic trioxide in squamous cell lung carcinoma
    Leanne Lee Leung et al, 2017, Oncology Letters CrossRef
  10. Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma
    SZE-KWAN LAM et al, 2015, International Journal of Oncology CrossRef
  11. Paradoxical effects of arsenic in the lungs
    Caixia Ren et al, 2021, Environmental Health and Preventive Medicine CrossRef
  12. Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II
    Harinder Gill et al, 2023, Frontiers in Oncology CrossRef
  13. Extracellular signal-regulated kinase 8-mediated NF-κB activation increases sensitivity of human lung cancer cells to arsenic trioxide
    Dan-Dan Wu et al, 2017, Oncotarget CrossRef